Skin hyperpigmentation following intravenous polymyxin B treatment associated with melanocyte activation and inflammatory process-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Skin hyperpigmentation following intravenous polymyxin B treatment associated with melanocyte activation and inflammatory process

Published:2017-05-11 Issue:5 Volume:42 Page:573-578
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Mattos K. P. H.¹,Cintra M. L.¹,Gouvêa I. R.²,Ferreira L. Á.³,Velho P. E. N. F.¹³,Moriel P.¹²

Affiliation:

1. Faculty of Medical Sciences; University of Campinas; Campinas SP Brazil

2. Faculty of Pharmaceutical Sciences; University of Campinas; Campinas SP Brazil

3. Dermatoscopy and melanoma Department of the Clinical Hospital of University of Campinas; Sao Paulo SP Brazil

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcpt.12543/fullpdf

Reference18 articles.

1. Clinicopathological correlation of acquired hyperpigmentary disorders;Patel;Indian J Dermatol Venereol Leprol,2013

2. Human skin pigmentation: melanocytes modulate skin color in response to stress;Costin;FASEB J,2007

3. Diffuse cutaneous hyperpigmentation due to tigecycline or polymyxin B;Knueppel;Clin Infect Dis,2007

4. Head and neck hyperpigmentation probably associated with polymyxin B therapy;Zavascki;Ann Pharmacother,2015

5. Acquired skin hyperpigmentation following intravenous polymyxin B treatment: a cohort study;Mattos;Pigment Cell Melanoma Res,2016

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety Factors Related to Plasma Concentration-Optimized Polymyxin B Therapy in Treating Carbapenem-Resistant Gram-Negative Bacterial Infections in China;Infection and Drug Resistance;2024-07

2. A pharmacovigilance study of adverse events associated with polymyxins based on the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) database;Expert Opinion on Drug Safety;2024-05

3. Molecular mechanisms underlying Tao-Hong-Si-Wu decoction treating hyperpigmentation based on network pharmacology, Mendelian randomization analysis, and experimental verification;Pharmaceutical Biology;2024-03-31

4. Clinical Efficacy and Safety of Colistin Sulfate in the Treatment of Carbapenem-Resistant Organism Infections in Patients with Hematological Diseases;Infectious Diseases and Therapy;2024-01

5. Understanding the Harmful Impact of Polymyxins on Acinetobacter baumannii;Acinetobacter baumannii - The Rise of a Resistant Pathogen [Working Title];2023-12-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3